BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20206885)

  • 1. Hepatocellular carcinoma: comparison of two different periods at the same center.
    Soresi M; La Spada E; Giannitrapani L; Campagna E; Di Gesaro V; Granà W; Sandonato L; Brancatelli G; Rotolo G; Affronti A; Messina S; Montalto G
    Eur J Intern Med; 2010 Apr; 21(2):127-30. PubMed ID: 20206885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
    Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.
    Franceschi S; Montella M; Polesel J; La Vecchia C; Crispo A; Dal Maso L; Casarin P; Izzo F; Tommasi LG; Chemin I; Trépo C; Crovatto M; Talamini R
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):683-9. PubMed ID: 16614109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical features and survival of patients with hepatitis B- and hepatitis C-associated hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Suwangool P; Mahachai V
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S250-6. PubMed ID: 12929997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hepatocellular carcinoma. Relation between serum and liver alpha fetoprotein, B virus infection, histology].
    Maggi G; Bighellini K; Borghi L
    Minerva Dietol Gastroenterol; 1985; 31(4):627-33. PubMed ID: 2418386
    [No Abstract]   [Full Text] [Related]  

  • 11. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors and prevention of hepatocellular carcinoma].
    Tanaka K
    Fukuoka Igaku Zasshi; 1997 Oct; 88(10):325-30. PubMed ID: 9432489
    [No Abstract]   [Full Text] [Related]  

  • 13. Age-related comparison of the profiles of patients with hepatocellular carcinoma.
    Fujishima T; Ishikawa T; Shiratori Y; Kanda M; Tateishi R; Akamatsu M; Koike Y; Sato S; Obi S; Hamamura K; Teratani T; Shiina S; Yoshida H; Kawabe T; Omata M
    Hepatogastroenterology; 2006; 53(72):913-8. PubMed ID: 17153452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrence rates and prognosis after hepatectomy on the patients with hepatocellular carcinoma compromised with HCV hepatitis--comparison between B, BC and NBNC type].
    Une Y; Kamiyama T; Misawa K; Nakanishi K; Uchino J
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):815-20. PubMed ID: 7563882
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.
    Ikeda K; Saitoh S; Koida I; Arase Y; Tsubota A; Chayama K; Kumada H; Kawanishi M
    Hepatology; 1993 Jul; 18(1):47-53. PubMed ID: 7686879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High risk group for development of hepatocellular carcinoma].
    Koike Y; Shiratori Y
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma: status in the era of liver transplantation.
    Singhal A; Jabbour N
    J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731
    [No Abstract]   [Full Text] [Related]  

  • 19. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.